The Veterinary Medicines Directorate (VMD) has granted MSD Animal Health a provisional UK marketing authorisation for Bovilis SBV, the first vaccine specifically targeting the Schmallenberg virus (SBV) in cattle and sheep.
SBV, which emerged in late 2011, is transmitted via insect vectors, mainly midges and causes transient clinical symptoms in adult cattle and sheep, such as fever, diarrhoea and reduced milk yield, as well as congenital malformation in newborn calves and lambs. As of March 31st 2013, 1753 cases of SBV had been confirmed throughout the UK. SBV has now been detected in every county in England and Wales.
Andras Bolcskei, Country Manager, MSD Animal Health UK said: "On behalf of Merck MSD, we would like to thank the VMD for its partnership and support to fast track the availability of Bovilis SBV to the market. There was a tremendous urgency for a SBV vaccine in the UK especially given the marked increase in confirmed cases over the past year and the increasing importance to help control this devastating disease."
MSD says that studies it conducted in support of the provisional marketing authorisation showed that all animals responded with formation of virus neutralizing antibodies. During the studies, reduced viraemia against SBV was observed in sheep vaccinated once and prevention of viraemia was observed in cattle vaccinated twice, whereas all animals in the control groups developed infection and became viraemic. In studies to date, Bovilis SBV has been shown to be efficacious in cattle and sheep.
The vaccine is based on wild-type SBV that has been inactivated and contains an adjuvant that stimulates the immune response.
The vaccine will be available in 20ml and 100ml vials. Bovilis SBV is indicated for the active immunisation of cattle to prevent viraemia against SBV and for the active immunisation of sheep to reduce viraemia against SBV.
MSD says it is working diligently to expedite stocks to the UK, and expects Bovilis SBV to arrive in the UK in the coming weeks.
Zoetis has announced the availability in the UK and Ireland of Poulvac IBQX, the first specific vaccine against the QX strain of the infectious bronchitis virus.
For the past two years the vaccine has only been available with a special import certificate from the Veterinary Medicines Directorate for use on flocks where the QX virus has been isolated.
According to the company, this variant IB strain has been an increasing problem in European countries over the last 10 years and was first seen in the UK in South-East England in 2007. Since then QX has been isolated from a number of commercial layer and broiler flocks, leading to inferior performance and increased mortality.
James Porritt, Zoetis Poultry Manager for the UK and Ireland said: "Poulvac IB QX adds another protection dimension to our extensive IB vaccine portfolio. The Zoetis IB portfolio offers the widest choice and with Poulvac IBMM + ARK we have the UK's only bivalent live vaccine licensed for day-old use providing a Massachusetts strain and protection against 793/B/91 variant type strains lasting for six weeks post vaccination. Other IB Vaccines include Poulvac H120 and the UK's only other bivalent live vaccine Poulvac IB Primer."
Poulvac IB QX vaccine is based on a live attenuated virus and is administered as a coarse spray to broilers from day-old and to layer pullets or broiler breeders from seven days of age. Protection has been demonstrated by challenge study to last for 63 days after vaccination.
Zoetis says the vaccine is often used on the farm, but can be administered to chicks at the hatchery if adequate controls are in place to avoid spread to other chicks that will be moved to non-QX exposed flocks.
Dr Stuart Andrews, Poultry Veterinary Manager for Zoetis said: "In countering the QX virus strain some existing vaccines have been used to provide a degree of cross-protection. However, it is important to appreciate that Poulvac IB QX is a vaccine homologous to any IB QX field strain and so will provide even better protection.
"Furthermore, our in-house PCR and DNA sequencing service allows us to monitor carefully the field situation to ascertain which IB strains are currently causing field outbreaks and enable us to recommend adaptations to particular vaccination programmes.
"The full approval for the Poulvac vaccine will make it easier and more effective to tackle specific QX infections without having to apply for an import certificate."
The challenge is part of Merial’s #CALFMATTERS calf pneumonia vaccination awareness campaign.
In total, the group aims to walk over 70,500 miles and raise £15,000 for Farm Africa, a charity which helps farmers and communities in developing countries by giving the advice and products they need to lift themselves out of poverty.
So far the challengers have covered one fifth of their total target, and completed the equivalent of several iconic distances including the Appalachian Trail, Lands End to John O’Groats, and ‘virtually’ crossed entire countries including Australia, China and Japan.
The participants have committed to the challenge by upping their physical activity. Merial has provided them with Fitbit fitness trackers to record their daily steps, which count towards the virtual teams’ total progress. The goal is 141 million steps in 20 weeks.
Robert Smith MRCVS from Farm First Vets is one of the highest steppers of the group. He recently scaled Ysgyryd Fawr (The Big Skirrid), one of the Black Mountains in Wales’ Brecon Beacons, for the challenge. He said: "I used to think of myself as a coiled spring ready for action, but the steps challenge has forced me to realise there is plenty of scope to increase my activity levels significantly. Hopefully when it is all over I will see the benefits and feel physically fitter for it."
Robert has taken the challenge one step further by encouraging his wife, two daughters, and Farm First Vets practice staff to join him in the challenge, with an added incentive. Between now and the BCVA Congress on 19th October, Farm First Vets will donate £50 to Farm Africa for every member of Robert’s team who completes the #CALFMATTERS challenge. Additionally, for every member of staff that achieves an average of 10,000 or more steps per day, the practice will donate £50 to XL Vets’ and BCVA 50th Anniversary charity, Send a Cow.
If you want to support those taking part in the challenge, you can do so at: www.justgiving.com/fundraising/calfmatters.
Identics, an animal identification company run by veterinary surgeon Egbert de Vries, has launched Labtags, a system with which you can tag animals and takes tissue samples simultaneously.
Egbert said: One of the diseases for which this tag has proven to be useful is Bovine Viral Diarrhoea (BVD). BVD Antigen testing is an important method of identifying the persistently infected (PI) animals in a herd.
"Use of labtags can be integrated in an accreditation scheme to achieve BVD Free status. It removes the need for taking blood samples and therefore simplifies the implementation of the accreditation scheme.
"BVD Antigen testing is not solely used for achieving an accreditation status. Persistently infected (PI) animals in your herd allow for the circulation of the BVD virus and have a negative impact on herd fertility and calf health. Identifying these animals is necessary for good herd management."
Two different labtags are available from IDENTICS. The first is the green button tag with a sequential number, which can be used as a complimentary tag to your double tagged animal. The second is a DEFRA approved tag with your UK herd number and individual animal number, allowing you to tag and sample your newborn calves with the correct tag without any extra work.
For more information, visit www.identics.co.uk, start a conversation with Egbert, email: info@identics.co.uk, or telephone: 01994 342100 / 07787 420646
The government has confirmed that tests carried out on a poultry farm in Dunfirmline have indicated the presence of a notifiable strain of avian influenza.
At this stage, officials say that the clinical picture indicates that this is a low pathogenic strain which poses little risk to human health.
All birds at the premises - 40,000 according to the Daily Mail - will be humanely culled, and a 1km Temporary Control Zone has been put in place to prevent the movement of birds, carcasses and eggs.
BVA President Sean Wensley said: "This suspected outbreak is further evidence of the vital surveillance role played by frontline vets in protecting animal and, by extension, human health. We commend the veterinary surgeon involved in detecting the outbreak in Fife, which has enabled a swift and effective response by the Scottish Government and all other organisations involved.
"We urge poultry keepers and vets working in the area to remain vigilant and to report any concerns to their local Animal Plant & Health Agency (APHA) office. We would like to emphasise that there is no food safety risk to the public."
Photo: RonaldDuncan at en.wikipedia
The award, introduced in 2020 and supported by animal health company Krka UK, recognises an exceptional farm vet who has been working in the dairy industry for three to five years and who has contributed significantly to the health and wellbeing of herds under their care.
The winner of the first award, in 2021, was Rob Hall from LLM Farm Vets in Shropshire. He said: "The sustainability of the dairy industry will remain in the spotlight for decades to come with young vets in a great position to work with dairy farmers of the future to improve the efficiency of their herds. This can be achieved, for instance, by improving nutrition, genetics and housing; by helping farmers to reduce antibiotics or wormers; and by reducing the detrimental effects of disease.”
He added: “As vets start their post-university careers, they face a steep learning curve. Dairy vets, in particular, have a huge arsenal of practical skills to hone, as well as trying to forge relationships with farmers and colleagues. It can be tricky to strike the right balance, while finding time to pursue their own interests to keep work interesting. I’ve been lucky at LLM to have had the opportunity to work with a great team and engaged farmers. This has enabled me to pick up the basics, as well as being able to delve deeper into the aspects of farming which interest me most. I’m extremely grateful to The Cream Awards for recognising this and to KRKA for its support of the Young Dairy Vet Award.”
Charlotte Read (pictured right), Krka Key Account Manager – Farm, added: “Krka is proud to support the recognition of rising stars within the dairy veterinary profession and hope that their achievements will inspire many of the next generation of veterinary surgeons to embrace the rewarding life of the farm vet.”
Full details of all of the CREAM Awards and the nomination process is available at: https://creamawards.uk
The first steps have begun to find Petplan and The Veterinary Business Journal's Practice Manager of the Year for 2012.
Nominations are now being sought for the most accomplished UK practice managers and recommendations are welcome from any member of the veterinary team.
Three finalists will be chosen and the winner announced at the annual Petplan Veterinary Awards in April 2012.
Robin Fearon, editor of the Veterinary Business Journal, said: "It is a distinct pleasure to launch the awards programme each year knowing that at the end of it we will be able to announce another winning practice manager.
"These awards are so important in promoting the role and highlighting the crucial part that managers play in practice strategy and success - we can't wait to see your nominations."
Judges will assess candidates' applications and choose the three finalists based on their competency in areas such as staff development, financial strategy and marketing initiative.
Last year's winner Denise Coston is practice manager at Castle Veterinary Surgeons in County Durham. She said: "Winning this award has meant a lot to me because it makes you feel valued. I would say to anyone thinking of nominating their practice manager: 'just do it'.
"The role of practice manager varies in each practice and can be hard to quantify with specific measures, but it means a lot to celebrate someone getting it right. It is an excellent way to promote the role of practice manager and it is great to get recognition alongside vets and nurses."
This award is supported by the Society of Practising Veterinary Surgeons and the Veterinary Practice Management Association.
As well as a plaque commemorating their achievements, the winner will once more receive one year's free membership to the VPMA.
Nominations for this year's award close on 10 February 2012. Application packs are available from: Jackie Morrison, The Veterinary Business Journal, Olympus House, Werrington Centre, Peterborough PE4 6NA, or e-mail jackiemorrison@vbd.uk.com.
Alternatively visit www.vetsonline.com/ to download yours direct.
Intervet/Schering-Plough Animal Health has announced the replacement of its Bovilis® IBR with Bovilis® IBR Marker Live vaccine, a move that brings the UK into line with the rest of Europe where marker vaccines are favoured.
Many EU member states, including Scandinavia and Austria are now declared IBR-free, and others (Germany and Hungary) operate national eradication programmes. Using a marker vaccine will help farmers wishing to export animals, or semen, or those working towards an eradication programme in their herds.
Recent bulk milk and blood screening via Intervet/Schering-Plough's complimentary BeefCheck and DairyCheck has revealed that 72% of herds tested were positive for IBR exposure. Given the latent nature of infection, and the rumbling losses associated with subclinical disease, it should come as no surprise that farmers are increasingly interested in controlling IBR. Studies have shown that IBR infection can result in a milk yield reduction of 173 litres per infected animal, or over £400 a year, for a 100-cow herd.
According to Intervet/Schering-Plough, Bovilis IBR Marker Live is Europe's leading IBR vaccine. It can be given intra-muscularly or intra-nasally to calves as young as two weeks old, as well as pregnant dams. It is also licensed to be given together with the pneumonia vaccine Bovilis® Bovipast RSP. The primary course involves one dose in cattle over three months of age, with immunity in just four days from the intra-nasal method, and 14 days from injection. Stock need re-vaccination every six months.
The vaccine reduces the amount of virus excreted into the environment, so minimising the risk to stressed cattle which may have been brought into the herd, and be latently infected. It also makes it an excellent choice for producers with breeding bulls, which should not be vaccinated. Bulls have to be kept naïve, however, the marker vaccine can be used on females in the herd to minimise virus circulation. This way the threat is minimised, and bulls can be kept infection free.
Every UK-based veterinary surgeon that registers as a member of www.vetsurgeon.org by 1st November 2010 will be entered into a draw to win an Apple iPad 32GB Wi-Fi worth £500.
All existing veterinary surgeon members will also be entered into the draw automatically, so there's no need to re-register. Still, you might like to spread the word about the draw amongst colleagues.
Full terms and conditions are available by clicking here.
Ceva Animal Health has produced a new advisory leaflet about enzootic abortion control and vaccination strategy in sheep to help vets explain the best prevention protocols to clients.
According to the company, it is estimated that around half of the 400,000 infectious abortions in UK sheep each year are from enzootic abortion caused by Chlamydophila abortus, but timely vaccination programmes can prevent such dramatic losses.
The eight-page leaflet explains how enzootic abortion can spread, why prevention is better than cure, the importance of timely vaccination of ewe lambs and replacement stock, how vaccination programmes make good economic sense and the benefits of using Cevac Chlamydia, Ceva Animal Health's live enzootic abortion vaccine as part of the control programme.
Carol Atkinson, reprodAction's product manager said: "Cevac Chlamydia receives consistently good feedback from vets, many of whom have enthusiastically volunteered their praise for the product to our territory managers. We thought a leaflet would be a constructive way to share views, giving vets the chance to hear about the advantages of vaccination and to provide them with the tools to explain to their clients why vaccinating against enzootic abortion is cost worthy."
For further information contact Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
MSD Animal Health has launched a new Chronogest CR pack for practices starting a dialogue with sheep producer clients about planned breeding for 2013 lamb sales, and is offering a free applicator with every four packs purchased.
The Chronogest CR intra-vaginal sponges, impregnated with 20mg of cronolone (flugestone acetate) synthetic hormone, are now available in foil wrapped packs of 25. The packs protect the sponges from light and moisture.
MSD is reminding practitioners that sponging programmes must be planned at least six weeks in advance of mating, with PMSG-Intervet injections essential at sponge removal.
The new packs of 25 will be available when existing 25, 50 and 100 pack sizes sell out.
Further information on planned breeding - including newsletter copy and sheep producer advisory materials - is available from the MSD Animal Health veterinary support group (VSG) on 01908 685685 or via emailing vet-support.uk@merck.com
Intervet/Schering-Plough Animal Health has announced that it has received approval for the intramuscular (IM) route of administration of Nuflor Minidose 450 mg/ml, a florfenicol-containing broad-spectrum antibiotic for the management of bovine respiratory disease (BRD).
Nuflor Minidose was approved initially in 2008 for subcutaneous (SC) use only and the now approved IM administration route is a line extension. According to Intervet/Schering Plough, IM administration (20 mg/kg administered twice, 48h apart) offers additional flexibility for the veterinary surgeon when treating cattle for BRD.
The company adds that Nuflor Minidose is the florfenicol injectable formulation which offers the lowest injection volume, which in particular is practical when treating heavier animals (thereby avoiding large injection volumes). The withdrawal period after IM administration of NUFLOR Minidose is only 37 days and is considerably shorter as compared to 64 days after SC use (40 mg/kg body weight injected once).
Francis Adriaens, Global Marketing Director, Global Ruminants Business Unit at Intervet/Schering-Plough Animal Health said: "Our customers requested the IM claim when Nuflor Minidose was first introduced and we are delighted to be able to recommend this route of administration hence forth."
Nuflor Minidose is indicated for preventive and therapeutic treatment of BRD in cattle caused by Mannheimia haemolytica, Pasteurella multicoda and Histophilus somni susceptible to florfenicol. The presence of the disease in the herd should be confirmed before administering preventive treatment.
Bimeda has announced the launch of a new teat seal which the company claims offers a significant return on investment and an opportunity for veterinary surgeons to prompt farmers to re-evaluate their dry cow therapy and mastitis control.
Bimeda's vet and head of technical services, Padraig Hyland MVB said: "Boviseal is proven to dramatically reduce mastitis in the 100 days post calving¹. Adding competition to the market will encourage farmers to re-assess their dry cow and mastitis strategies.
"The UK launch of Boviseal is a great opportunity for vets to raise the issue of the damage and cost of mastitis, and the potential savings by the correct use of a seal. Boviseal is the number one selling teat seal in the Republic of Ireland, with 2/3 of the Irish dairy cows sealed annually²."
Padraig says the evidence of the value from combined sealing and antibiotic therapy is all too clear when it comes to dry cow therapy. He cites a case study at Waterwheel Farm in Donegal, Ireland which delivered a 300% return on investment: "Combined therapy might sound costly but this two year study saw annual mastitis cases fall dramatically, from 26 per 100 cows to 9 per 100³.
"Defra figures indicate that mastitis is the most costly disease problem that UK dairy farmers face, with a typical case costing £175.00 4. When you compare that against the cost of treatment for the herd, there's no real counter argument in my opinion."
Boviseal contains 65% Bismuth Subnitrate. Padraig says the effectiveness of teat sealing is proven but correct administration is key: "It is important to note that the conventional practice of massaging into the udder after infusion is not employed - the teat seal must stay in the teat canal."
For details on best application practices, the company has developed a website, www.boviseal.co.uk with a video demonstration for correct infusion.
For further information, visit the website or contact Bimeda on 01248 725400.
References
Ceva Animal Health has launched ReprodAction, a new series of webinars to help address the problems commonly faced in bovine reproduction management.
James Husband, RCVS Specialist in Cattle Health and Reproduction, kicked off the series at the beginning of November with a live webinar for XLVet members: Assessing Fertility Records.
His presentation, which is now accessible to all large animal vets at http//onsync.digitalsamba.comn/go/ceva/ReprodAction, explores the common pitfalls and provides practical pointers for good fertility management. He discusses the limiting factors of oestrus detection, use of the calving interval as an assessor of individual fertility performance, implications of the varied definitions of conception rates, use of milk recording organisation data and the usefulness of the 21 day in calf rate.
Each webinar in the series is presented by a leading expert and has a facility for live chat and question and answer sessions.
For further information and details of when the next ReprodAction webinar will be taking place, contact Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.
The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.
From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.
The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.
Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.
"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."
For more information, visit: http://www.westpointveterinarygroup.com
Grahame Gardner Ltd has announced the launch of a classically styled tunic, the M559, now stocked in bottle green for the first time.
The company says that although there have been numerous ladies tunics available in bottle green, this is the first time Grahame Gardner has stocked a male tunic in the characteristic veterinary colour.
The contemporary design of the M559 incorporates side fastening with the option of contrasting epaulettes, alongside practical pockets and side slits. According to the company, it's a tunic that looks great and performs exceptionally well in the veterinary practice. Stocked in sizes from 34" to 50" (chest), the M559 is one of several new styles introduced within Grahame Gardner's latest 124 page brochure.
To explore Grahame Gardner's collection please take a look at http://www.grahamegardner.co.uk/, or call 0116 255 6326 to order a copy of the new brochure.
Sioned Timothy, Ruminant Technical Manager at Boehringer said: "The financial and production impact of liver fluke should not be underestimated. Recent abattoir research in Ireland, published this year, has shown that a fattening steer with fluke infection will put on 36kg less live weight gain over its lifetime versus a healthy steer, costing the producer around £63, per animal.
"Additionally, analysis of data from cattle at a Scottish abattoir showed that animals with 1 to 10 liver fluke present in their liver took an average 31 days longer to reach slaughter weight, while animals with more than 10 liver fluke present took an additional 77 days longer to reach slaughter weight versus animals without any liver fluke infection2.
"Liver fluke infections can also lead to hormonal and metabolic imbalances, affecting reproduction in female animals and extending breeding targets3. Affected animals may also be more susceptible to secondary bacterial infections, such as Salmonella and Clostridial infections3."
Boehringer says that with cattle being brought in for winter housing, now is an ideal opportunity to remove productivity-limiting parasites that were acquired during the grazing season. The main targets for parasite control at this time of year are gutworms, lungworm and liver fluke, however the specific risk will vary from farm to farm.
The company adds that the choice of treatment for liver fluke at housing is complicated by emerging resistance to triclabendazole. This is the only flukicide that treats the early immature stage of liver fluke, responsible for acute disease in sheep but not of clinical relevance in cattle.
Sioned said: "Prescribing an alternative flukicide for cattle at housing will reduce selection for resistance and, by targeting the later stages of the parasite, control the impact of liver fluke on productivity.
"Flukicides containing clorsulon (contained in Ivomec Super) will remove the adult stages of fluke in cattle, while those containing closantel, or nitroxynil (the active ingredient of Trodax), are effective against both late immature and adult stages.
"To ensure that cattle have no residual fluke burden, they may need to be re-treated at an appropriate interval after the initial housing dose. Diagnostic testing can be used to determine whether a second treatment is necessary. This approach will ensure that cattle are turned back out onto pasture fluke free."
The National Office of Animal Health has issued a statement criticising the All Party Parliamentary Group on Antibiotics report: "Non-human uses of antibiotics: time to restrict their use?”, saying it fails to recognise the steps that have already been taken by vets and farmers to prevent disease and minimise antibiotic use on farms where possible.
NOAH chief executive Dawn Howard said: "NOAH fully supports the need for responsible prescribing, by both the veterinary and medical professions.
"On the veterinary side, NOAH has been very actively involved with responsible use initiatives, such as the RUMA Alliance, which publishes guidelines supporting responsible use and has produced an action plan on livestock antibiotic resistance to implement Government strategy.“
NOAH highlights two particular aspects of the report. Firstly that it is critical of the treatment of groups of animals through medicated feed and water.
Dawn said: "There are many animal-friendly reasons why medicines can be prescribed in this way by a veterinary surgeon.
"For groups of animals, fish or birds there is less stress than injection or individual oral dosing. Where treatment is needed, the vet supplies a prescription for treatment through medicated feed or through the water, depending on the product being used. The whole process is highly regulated through European and national legislation."
The report also suggests certain classes of antibiotics should be reserved for humans. NOAH says it believes that veterinary surgeons need to retain the full range of currently licensed antibiotics in order to be able to treat the range of conditions that affect animals, and if they are restricted, animal welfare will undoubtedly suffer.
NOAH adds that removal of some classes from the veterinary sector would place undue selective pressure on the remaining classes which could increase resistance to those classes – having the opposite effect to what the committee probably intends.
Dawn said: “NOAH is disappointed not to have been consulted in advance of the publication of the report. We believe that responsible use of veterinary antibiotics is the best way to help preserve these precious medicines for us all, without compromising the health and welfare of our animals.”
The webinar is being hosted by Dr William Ingham Farrow from Poultry Health Services (PHS), part of the VetPartners group.
William said: “Having worked with a wide variety of different avian species and management systems for over 10 years, I’m delighted to be sharing my experience.
"I hope to bring plenty of useful insight to help young vets gain confidence in this area.
“In this session, I’m aiming to provide advice for first-opinion vets working with both individual hens and backyard flocks.
“I hope to show that you don't need specialist equipment or medication to offer veterinary care for these often overlooked clients, and to signpost the additional help available in more complex cases."
The webinar is part of the Farm Animal Veterinary Society's Car Pool Cases series, which will also cover antibiotic selection (June 25th), camelid care (August 20th), downer cows (October 22nd), youngstock (November 19th) and beef fertility (December 10th).
https://www.eventbrite.co.uk/e/carpool-cases-practical-pointers-from-front-line-farm-vets-tickets-640902997117
To submit questions ahead of the Carpool sessions, email: farmsupport@vetpartners.co.uk
www.favs.org.uk
Public Health England (PHE) is urging veterinary surgeons, nurses, other healthcare professionals and the public to become Antibiotic Guardians by visiting antibioticguardian.com and pledging to make better use of antibiotics, to help make sure they work now and in the future.
The website first asks users to choose whether they would like to make a pledge as a member of the public or as a healthcare professional or leader.
Those who pledge as a Healthcare Professional > Veterinary Practitioner can select one of the following pledges:
Those who pledge as a member of the public can elect to do so as an adult, a family member, a pet owner or a farmer.
The available pledges change according to category and those who respond will be asked if PHE can follow-up to confirm they did keep their pledge.
The campaign forms part of activities that support European Antibiotic Awareness Day (EAAD). Dr Diane Ashiru-Oredope, Lead for EAAD 2014 at Public Health England, said: "Everybody can help to tackle antibiotic resistance and we really urge people to help us do this. There is a lot to be done but we can start by making inroads into inappropriate prescribing.
"There are 2 elements to this. One is that we need patients to not always expect to receive an antibiotic for those self-limiting illnesses which are typically caused by viruses. This generally includes those where the symptoms include coughs, runny noses, muscle aches and fever. And the other is for GPs not to feel pressurised into prescribing antibiotics when they aren't really necessary.
"Community pharmacists and their teams also have a key role and should be seen as the first port of call for many winter illnesses caused by viruses. They can also help to manage patients' expectations by explaining the normal duration of these symptoms, what warning signs to look out for and providing effective over the counter treatments that will help relieve the symptoms.
Nicholas Brown, President at the British Society for Antimicrobial Chemotherapy (BSAC), said: "Recently published research in BSAC's Journal, Journal of Antimicrobial Chemotherapy, confirms that despite government recommendations to reduce prescribing for viral illnesses there are still many GPs who do this. Of course GPs don't want their patients to feel unwell but there are many medicines which are available over-the-counter which can really help to reduce symptoms and make people feel better.
"We want to encourage everyone to self-treat as much as possible when it is safe and appropriate to do so. By using antibiotics only when they are needed we can all help to make sure that we keep our antibiotics working for everyone in the future.
"Antibiotic resistance is one the biggest threats to public health and PHE is delivering 4 key aspects of the 5-year UK strategy to help combat antibiotic resistance. These are improving infection prevention and control practices to reduce the number of infections in patients; optimising prescribing practice, improving professional education, training and public engagement and enabling better access to and use of surveillance data."
Children learn lots of important lessons about life, sickness and death from animals and veterinary practitioners. There seems to be an important role here for the profession to educate adult animal owners why antibiotics need to be used carefully both in pets and in humans.
Dickson Company has launched the Dickson Alarm Thermometer, a tool to ensure that vaccine and drug storage temperatures in both refrigerators and freezers fully comply with regulatory requirements.
Featuring tamper-resistant audible and visual alarms, the Dickson Alarm Thermometer costs US$59 for a two probe model (MM125) that can monitor both refrigerators and freezers simultaneously and US$49 for a single probe model (MM120).
Both the MM125 and MM120 models are continuous, calibrated and certified thermometers that are able to monitor temperatures in the -58 to +158°F (-50 to +70°C. For more technical details on Dickson Alarm Thermometers see (www.dicksondata.com/product/model_MM120.php).
Product inquiries can be directed to Dickson customer service at dicksoncsr@dicksondata.com, or calling 800-757-3747 or +1-630-543-3747 outside the US, FAX +630-543-0498 or by writing Dickson, 930 South Westwood Avenue, Addison, IL 60101, USA.
The RCVS Disciplinary Committee has reprimanded a veterinary surgeon for submitting a certificate of Clinical Inspection for Veterinary Inspectors ("TB52") for tuberculin tests he had undertaken on cattle, despite knowing that he had not fully complied with the standard operating procedures (SOP) for these tests.
At the outset of the three-day hearing, John Wilson admitted that, when acting as an Official Veterinarian (OV) he had not carried out tuberculin tests on cattle at a Wiltshire farm on 19 May 2011 strictly in accordance with the SOP required by the Animal Health and Veterinary Laboratories Agency (AHVLA), an executive agency of Defra.
The admitted shortcomings were that on 19 May, the second day of testing, Mr Wilson had failed to confirm the identity of all the animals, failed to inspect the animals digitally (ie using his hands) and had not measured the fold of skin at the injection site of all the animals. The College argued that this was contrary to the directions of the AHVLA and, in subsequently signing the TB52 certificate, he was either dishonest or should have known that the certification was incorrect. Mr Wilson admitted that he ought to have known the certification was incorrect but denied dishonesty, because he believed that he had conducted the test in a satisfactory manner and had correctly identified all the reactors in the herd.
Mr Wilson was a veterinary surgeon of over 40 years experience and unblemished record, and the Committee found his account of events to be accurate and honest. He said the farm involved was unprepared and test arrangements were chaotic, with poor handling facilities, and he would have been concerned for the safety of the animals and their handlers if he had complied fully with the SOP. He had advised the farmer to delay the test but his advice was rejected.
The Committee accepted that the testing had been carried out under exceptional and difficult circumstances. It noted that Mr Wilson had identified a reactor and taken appropriate actions, knowing that the outcome would be the quarantining of the whole herd. He had made no financial or other gain, other than the nominal fee charged for the work. Although failing to comply with the SOP fell short of what was expected of a veterinary surgeon, because of these circumstances, and as he had acted in what he considered to be the best interests of the animals and personnel, these actions did not amount to serious professional misconduct.
The Committee found that, even allowing for these difficulties and concerns, in signing the TB52 certificate a few days later, without any qualification, Mr Wilson ought to have known that it was incorrect, and his actions fell far short of the standards expected of the veterinary profession. They did not however find that he had been dishonest.
The Committee stressed the importance attached to accurate and reliable certification, in maintaining the confidence of the public and the profession, and in ensuring animal welfare.
Professor Lees, chairing and speaking on behalf of the committee said: "The Committee is aware, as confirmed by AHVLA, that this is a single, isolated event and the first offence in some 40 years of the Respondent working as a LVI [local veterinary inspector] or OV. After considering all the mitigating factors.and, given the exceptional circumstances of this specific case, the decision of the Committee is to reprimand Mr Wilson."
Free-range table-birds being reared from slower growing breeds need a different vaccination regime from that of faster-growing broilers, when being immunised against Gumboro disease.
This previously-unknown fact has emerged from laboratory and field trials, involving several hundred thousand birds on farms throughout the UK, carried out by Lohmann Animal Health in conjunction with poultry vets.
"When using a ‘hot' vaccine conventional broilers in the UK are normally vaccinated at around 14-16 days when their maternal immunity is waning," said Adam Goddard, Lohmann's UK sales consult. "However, we've found this maternal immunity lasts longer in the slow-growing breeds which are reared both indoors and out."
Realistically, the correct day of vaccination for free-range table-birds is more likely to be achieved by using the vaccine date predictions for broiler-breeders, rather than that of the broiler, under the Deventer formula, which gives calculations for different types of bird.
He therefore advises producers to consult their vets who can take blood samples to get an accurate prediction regarding optimum timing of vaccination with their own particular flocks.
"Our trials have shown that, in general, and depending upon the breed used, the decline in maternal immunity is delayed - perhaps for 4-5 days. So, in order to get a better ‘take', we recommend vaccinating these birds later or using an IBD vaccine that ‘takes' in the presence of high maternal immunity." said Mr Goddard.
Gumboro disease - also known as Infectious Bursal Disease - can cause severe losses in chickens and outdoor-reared birds are more susceptible to the disease due to environmental influences.
Earlier this year Lohmann Animal Health launched a new ‘hot' vaccine, classified as an ‘intermediate plus' against the very virulent form of Gumboro disease. The company says that because of its ability to break through high levels of maternal antibodies, it allows vaccination to take place earlier than with other existing vaccines.